BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Significant Growth in Short Interest
by Doug Wharley · The Cerbat GemBioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totaling 46,393 shares, a growth of 433.3% from the April 30th total of 8,700 shares. Based on an average daily trading volume, of 3,299 shares, the days-to-cover ratio is presently 14.1 days. Currently, 0.0% of the company’s shares are short sold.
BioNxt Solutions Price Performance
BioNxt Solutions stock opened at $0.30 on Friday. The business has a 50 day moving average of $0.35 and a 200-day moving average of $0.42. BioNxt Solutions has a 1 year low of $0.14 and a 1 year high of $0.80. The company has a market capitalization of $36.39 million, a P/E ratio of -7.43 and a beta of 0.69.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last released its quarterly earnings data on Friday, May 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.